OPEN LABEL TRIAL OF ATOMOXETINE FOR ATTENTION DEFICIT HYPERACTIVITY DISORDER (ADHD) IN CHILDREN WITH SPECIAL EDUCATIONAL NEEDS

Update Il y a 4 ans
Reference: EUCTR2008-004827-44

Woman and Man

  • | Country :
  • -
  • | organs :
  • -
  • | Specialty :
  • -

Extract

What is the efficacy of atomoxetine in reducing the symptoms of ADHD among children with moderate and severe learning disabilities and ADHD?


Inclusion criteria

  • We will conduct a prospective, open-label pilot study of atomoxetine targeted toward symptoms of ADHD in children with learning disabilities and ADHD (Attention Deficit Hyperactivity Disorder)

Links